United States Edaravone Market Report 2016

November 2016 | 100 pages | ID: U6A8A06D61BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Edaravone

Revenue, means the sales value of Edaravone

This report studies sales (consumption) of Edaravone in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Mitsubishi Tanabe Pharma
• Simcere
• Taj Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd
• UCB India Ltd
• Piramal Healthcare

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Edaravone in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Edaravone Market Report 2016

1 EDARAVONE OVERVIEW

1.1 Product Overview and Scope of Edaravone
1.2 Classification of Edaravone
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Edaravone
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Edaravone (2011-2021)
  1.4.1 United States Edaravone Sales and Growth Rate (2011-2021)
  1.4.2 United States Edaravone Revenue and Growth Rate (2011-2021)

2 UNITED STATES EDARAVONE COMPETITION BY MANUFACTURERS

2.1 United States Edaravone Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Edaravone Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Edaravone Average Price by Manufactures (2015 and 2016)
2.4 Edaravone Market Competitive Situation and Trends
  2.4.1 Edaravone Market Concentration Rate
  2.4.2 Edaravone Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES EDARAVONE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Edaravone Sales and Market Share by Type (2011-2016)
3.2 United States Edaravone Revenue and Market Share by Type (2011-2016)
3.3 United States Edaravone Price by Type (2011-2016)
3.4 United States Edaravone Sales Growth Rate by Type (2011-2016)

4 UNITED STATES EDARAVONE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Edaravone Sales and Market Share by Application (2011-2016)
4.2 United States Edaravone Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES EDARAVONE MANUFACTURERS PROFILES/ANALYSIS

5.1 Mitsubishi Tanabe Pharma
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Edaravone Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Simcere
  5.2.2 Edaravone Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Simcere Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Taj Pharmaceuticals Ltd.
  5.3.2 Edaravone Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sun Pharmaceutical Industries Ltd.
  5.4.2 Edaravone Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Unichem Laboratories Ltd
  5.5.2 Edaravone Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 UCB India Ltd
  5.6.2 Edaravone Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Piramal Healthcare
  5.7.2 Edaravone Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 EDARAVONE MANUFACTURING COST ANALYSIS

6.1 Edaravone Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Edaravone

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Edaravone Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Edaravone Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES EDARAVONE MARKET FORECAST (2016-2021)

10.1 United States Edaravone Sales, Revenue Forecast (2016-2021)
10.2 United States Edaravone Sales Forecast by Type (2016-2021)
10.3 United States Edaravone Sales Forecast by Application (2016-2021)
10.4 Edaravone Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Edaravone
Table Classification of Edaravone
Figure United States Sales Market Share of Edaravone by Type in 2015
Table Application of Edaravone
Figure United States Sales Market Share of Edaravone by Application in 2015
Figure United States Edaravone Sales and Growth Rate (2011-2021)
Figure United States Edaravone Revenue and Growth Rate (2011-2021)
Table United States Edaravone Sales of Key Manufacturers (2015 and 2016)
Table United States Edaravone Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Edaravone Sales Share by Manufacturers
Figure 2016 Edaravone Sales Share by Manufacturers
Table United States Edaravone Revenue by Manufacturers (2015 and 2016)
Table United States Edaravone Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Edaravone Revenue Share by Manufacturers
Table 2016 United States Edaravone Revenue Share by Manufacturers
Table United States Market Edaravone Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Edaravone Average Price of Key Manufacturers in 2015
Figure Edaravone Market Share of Top 3 Manufacturers
Figure Edaravone Market Share of Top 5 Manufacturers
Table United States Edaravone Sales by Type (2011-2016)
Table United States Edaravone Sales Share by Type (2011-2016)
Figure United States Edaravone Sales Market Share by Type in 2015
Table United States Edaravone Revenue and Market Share by Type (2011-2016)
Table United States Edaravone Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Edaravone by Type (2011-2016)
Table United States Edaravone Price by Type (2011-2016)
Figure United States Edaravone Sales Growth Rate by Type (2011-2016)
Table United States Edaravone Sales by Application (2011-2016)
Table United States Edaravone Sales Market Share by Application (2011-2016)
Figure United States Edaravone Sales Market Share by Application in 2015
Table United States Edaravone Sales Growth Rate by Application (2011-2016)
Figure United States Edaravone Sales Growth Rate by Application (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma Edaravone Sales Market Share (2011-2016)
Table Simcere Basic Information List
Table Simcere Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Simcere Edaravone Sales Market Share (2011-2016)
Table Taj Pharmaceuticals Ltd. Basic Information List
Table Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taj Pharmaceuticals Ltd. Edaravone Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Ltd. Basic Information List
Table Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Ltd. Edaravone Sales Market Share (2011-2016)
Table Unichem Laboratories Ltd Basic Information List
Table Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Unichem Laboratories Ltd Edaravone Sales Market Share (2011-2016)
Table UCB India Ltd Basic Information List
Table UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB India Ltd Edaravone Sales Market Share (2011-2016)
Table Piramal Healthcare Basic Information List
Table Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2011-2016)
Table Piramal Healthcare Edaravone Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Edaravone
Figure Manufacturing Process Analysis of Edaravone
Figure Edaravone Industrial Chain Analysis
Table Raw Materials Sources of Edaravone Major Manufacturers in 2015
Table Major Buyers of Edaravone
Table Distributors/Traders List
Figure United States Edaravone Production and Growth Rate Forecast (2016-2021)
Figure United States Edaravone Revenue and Growth Rate Forecast (2016-2021)
Table United States Edaravone Production Forecast by Type (2016-2021)
Table United States Edaravone Consumption Forecast by Application (2016-2021)